Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Main Authors: Peyman Nowrouzi-Sohrabi (Author), Negin Soroush (Author), Reza Tabrizi (Author), Mojtaba Shabani-Borujeni (Author), Shahla Rezaei (Author), Fatemeh Jafari (Author), Mahnaz Hosseini-Bensenjan (Author), Bruno H. Stricker (Author), Mandy van Hoek (Author), Fariba Ahmadizar (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Whether liraglutide use improves cardiometabolic risk factors in different subsets of subjects with coronary artery disease (CAD) remains unclear. In a systematic review and meta-analysis, we quantified the effects of liraglutide on cardiometabolic risk profile in subjects with CAD with...